Breaking News

Abbott to buy Exact Sciences in $21B deal

November 21, 2025
What's a five-letter word often paired with "kangaroo" or "supreme"? Solve STAT's latest mini-crossword.
Samples at Exact Sciences' laboratory in San Diego.
Exact Sciences

STAT+ | Abbott to buy cancer screening test maker Exact Sciences in $21B deal

The deal, one of the biggest health care acquisitions this year, includes Exact's blood-based and stool-based cancer tests.

By Andrew Joseph


STAT+ | AI spun out of Berkeley proposes to detect hundreds of conditions on medical images

Radiologist and computer scientist team up in attempt to turn an open-source AI model into software that can spot hundreds of conditions on CT, MRI scans.

By Casey Ross


STAT+ | In new FDA role, Pazdur will decide the future of Sarepta's Duchenne drugs

In this week's edition of "Adam's Biotech Scorecard," Adam also lays out what he's grateful for in biotech this Thanksgiving season.

By Adam Feuerstein



Maksym Filipenko for STAT

STAT+ | How RFK Jr., America's celebrity health secretary, is steamrolling science

Kennedy, the nation's 26th secretary of Health and Human Services and arguably the most disruptive, examined in a revealing STAT deep-dive profile.

By Chelsea Cirruzzo, Casey Ross, and Sarah Todd


More around STAT

In case you missed it

  • Screenings could save four times as many people from lung cancer, a new study finds, New York Times
  • FDA approves new Bayer medicine that treats a common form of lung cancer, Bloomberg
  • US funding cuts imperil global efforts to eliminate cervical cancer, CNN

Check out more exclusive coverage with a STAT+ subscription
Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

Enjoying Cancer Briefing? Tell us about your experience
Continue reading the latest health & science news with the STAT app
Download on the App Store or get it on Google Play
STAT
STAT, 1 Exchange Place, Boston, MA
©2025, All Rights Reserved.

No comments